Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History C$1.60 -0.02 (-1.23%) As of 08/25/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Cardiol Therapeutics Stock Price Performance The Cardiol Therapeutics (CRDL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.30%, with a year-to-date return of -13.51%. In the past month, the stock has decreased 18.37%, reflecting recent market activity. As of the latest close, Cardiol Therapeutics traded at C$1.60 with a market cap of C$132.77 million and volume of 152,736 shares. Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.23%1 Month Performance-18.37%3 Month Performance+5.26%Year-To-Date Performance-13.51%1 Year Performance-40.30% CRDL Stock Chart for Tuesday, August, 26, 2025 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025C$1.62C$1.60-1.23%C$1.65C$1.56152,736 shsC$132.77 million08/22/2025C$1.62C$1.62C$1.67C$1.58140,196 shsC$134.43 million08/21/2025C$1.60C$1.62+1.25%C$1.65C$1.5571,706 shsC$134.43 million08/20/2025C$1.57C$1.60+1.91%C$1.64C$1.55181,379 shsC$132.77 million08/19/2025C$1.69C$1.57-7.10%C$1.69C$1.52241,437 shsC$130.28 million08/18/2025C$1.83C$1.69-7.65%C$1.85C$1.63313,190 shsC$140.23 million08/15/2025C$1.85C$1.83-1.08%C$1.95C$1.80341,500 shsC$151.85 million08/14/2025C$1.53C$1.85+20.92%C$1.87C$1.59550,459 shsC$153.51 million08/13/2025C$1.54C$1.53-0.65%C$1.67C$1.52260,264 shsC$126.96 million08/12/2025C$1.40C$1.54+10.00%C$1.58C$1.41297,598 shsC$127.79 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025C$1.40C$1.40C$1.46C$1.34350,181 shsC$116.17 million08/08/2025C$1.48C$1.40-5.41%C$1.50C$1.31328,893 shsC$116.17 million08/07/2025C$1.48C$1.48C$1.57C$1.48107,891 shsC$122.81 million08/06/2025C$1.85C$1.48-20.00%C$1.64C$1.47507,005 shsC$122.81 million08/05/2025C$1.91C$1.85-3.14%C$1.88C$1.78161,610 shsC$153.51 million08/04/2025C$1.91C$1.91C$2.05C$1.90143,893 shsC$158.49 million08/01/2025C$2.06C$1.91-7.28%C$2.05C$1.90143,893 shsC$158.49 million07/31/2025C$2.08C$2.06-0.96%C$2.15C$2.02124,003 shsC$170.94 million07/30/2025C$2.01C$2.08+3.48%C$2.13C$1.98134,230 shsC$172.60 million07/29/2025C$2.10C$2.01-4.29%C$2.14C$1.97142,863 shsC$166.79 million07/28/2025C$1.96C$2.10+7.14%C$2.17C$1.98267,396 shsC$174.26 million07/25/2025C$1.92C$1.96+2.08%C$1.97C$1.8783,203 shsC$162.64 million Related Companies Aimia Stock Price Chart International Tower Hill Mines Stock Price Chart Fennec Pharmaceuticals Stock Price Chart Graphite One Stock Price Chart Medicenna Therapeutics Stock Price Chart EQ Stock Price Chart Canadian Gold Stock Price Chart CI Canadian Convertible Bond ETF Common Stock Price Chart BioRem Stock Price Chart Relevant Gold Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CRDL) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access